data_2eyw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2eyw _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.507 -0.237 . . . . 55.030000000000001 112.507 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -80.46 82.7 6.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.765 0.317 . . . . 65.400000000000006 111.118 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 4.4 mmt -52.98 -18.95 2.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 74.310000000000002 110.885 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.6 133.07 11.6 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 72.040000000000006 112.494 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 53.3 p -105.81 -8.97 17.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.894 0.378 . . . . 53.109999999999999 110.845 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.32 56.15 0.79 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.754 -0.736 . . . . 54.329999999999998 112.474 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 89.1 t -112.19 133.48 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.831 0.348 . . . . 74.310000000000002 111.125 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.427 HG22 ' N ' ' A' ' 129' ' ' LEU . 35.0 mm -81.34 133.86 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 73.519999999999996 111.107 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.427 ' N ' HG22 ' A' ' 128' ' ' ILE . 8.2 mt -90.98 113.48 25.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 74.209999999999994 110.933 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -109.62 149.66 29.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 74.439999999999998 110.837 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -124.56 34.62 4.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 75.409999999999997 110.892 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -95.23 138.71 32.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 73.099999999999994 110.881 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -113.49 -75.49 0.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 75.049999999999997 110.897 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.402 ' CB ' ' HE1' ' A' ' 169' ' ' TRP . . . -174.78 135.92 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 73.409999999999997 111.07 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.401 ' HG3' ' HB2' ' A' ' 183' ' ' PRO . 4.3 mm-40 -95.61 118.86 33.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 73.319999999999993 110.863 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.848 ' HA ' ' HA ' ' A' ' 167' ' ' GLU . 0.9 OUTLIER -104.73 112.84 26.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 74.310000000000002 110.942 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.751 ' H ' ' N ' ' A' ' 168' ' ' GLN . 3.6 t -158.86 173.97 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 71.329999999999998 111.099 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.596 ' CA ' ' O ' ' A' ' 165' ' ' PRO . 6.5 ttt180 -113.71 148.03 37.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 74.140000000000001 110.863 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.66 ' CB ' ' CH2' ' A' ' 170' ' ' TRP . . . -62.09 131.55 49.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 64.420000000000002 111.073 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -134.12 -69.12 0.54 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 74.430000000000007 110.922 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -81.38 -176.95 6.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 74.239999999999995 110.888 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.5 ' O ' ' CG ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER -138.48 110.57 7.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 72.430000000000007 110.85 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 1.8 t80 -123.74 145.89 48.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 75.129999999999995 110.874 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -102.8 144.42 31.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 73.129999999999995 110.9 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -129.62 166.96 21.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.707 -0.759 . . . . 72.519999999999996 112.496 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -124.54 23.13 8.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.807 0.337 . . . . 73.239999999999995 110.854 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.438 ' CB ' ' OD1' ' A' ' 150' ' ' ASP . 1.1 m-20 -98.38 132.71 43.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 73.439999999999998 110.869 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -77.44 -29.87 53.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 75.209999999999994 110.836 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -88.86 18.72 4.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 74.510000000000005 110.884 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.504 ' HB3' ' CG2' ' A' ' 182' ' ' ILE . 0.2 OUTLIER -149.39 178.12 9.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 74.230000000000004 110.847 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.533 ' C ' HD13 ' A' ' 151' ' ' LEU . 1.1 tm? -145.4 134.12 10.99 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.592 0.711 . . . . 72.239999999999995 110.983 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.533 ' HD2' ' CD2' ' A' ' 151' ' ' LEU . 53.7 Cg_endo -69.73 137.96 36.77 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.248 . . . . 74.340000000000003 112.329 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.661 ' HB2' ' CZ3' ' A' ' 170' ' ' TRP . 24.6 p90 -89.28 143.99 26.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 73.400000000000006 110.882 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -109.84 162.03 14.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 73.439999999999998 110.911 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' A' ' 157' ' ' ASP . 10.7 ttpp -91.94 94.94 9.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 74.25 110.93 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 155' ' ' LYS . . . 30.6 32.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 60.100000000000001 112.514 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 155' ' ' LYS . 10.8 t0 -82.71 179.2 7.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.793 0.33 . . . . 75.439999999999998 110.863 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 23.3 mm -95.16 103.51 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 75.510000000000005 111.119 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.54 163.39 39.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 63.310000000000002 110.902 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.698 ' O ' ' O ' ' A' ' 173' ' ' GLU . 4.5 tpp85 -92.49 80.72 4.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 74.439999999999998 110.879 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.89 ' HA ' ' CB ' ' A' ' 172' ' ' ALA . 0.2 OUTLIER -148.16 119.82 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.17 -0.468 . . . . 74.299999999999997 111.166 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.65 ' H ' ' CB ' ' A' ' 172' ' ' ALA . 24.6 mtt180 -69.0 70.85 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 74.040000000000006 110.864 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.456 ' HA ' ' CG ' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -79.56 127.13 31.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 61.350000000000001 110.893 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.767 ' O ' ' O ' ' A' ' 167' ' ' GLU . 0.3 OUTLIER -83.56 119.04 73.15 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.563 0.697 . . . . 75.030000000000001 110.888 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.596 ' O ' ' CA ' ' A' ' 138' ' ' ARG . 53.6 Cg_endo -69.83 -53.52 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.658 2.239 . . . . 75.340000000000003 112.353 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.612 ' HA ' ' CD1' ' A' ' 190' ' ' TYR . 36.5 tt0 -75.16 -3.04 30.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 75.540000000000006 110.871 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.848 ' HA ' ' HA ' ' A' ' 136' ' ' TYR . 3.2 mt-10 -141.73 142.7 33.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.310000000000002 110.897 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.751 ' N ' ' H ' ' A' ' 137' ' ' VAL . 0.8 OUTLIER -83.96 24.58 0.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 73.140000000000001 110.914 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.631 ' C ' ' HD1' ' A' ' 170' ' ' TRP . 96.3 m95 -110.8 110.59 21.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 74.150000000000006 110.958 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.754 ' O ' ' HA ' ' A' ' 181' ' ' MET . 5.7 m0 -117.92 160.15 21.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.432 . . . . 74.439999999999998 110.952 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -160.87 104.98 1.36 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 63.299999999999997 110.937 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.89 ' CB ' ' HA ' ' A' ' 161' ' ' ILE . . . 173.13 177.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 73.209999999999994 111.147 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.698 ' O ' ' O ' ' A' ' 160' ' ' ARG . 16.4 tt0 -86.04 107.34 17.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 73.430000000000007 110.891 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.592 ' CG ' ' N ' ' A' ' 175' ' ' SER . 0.1 OUTLIER -72.67 174.22 7.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 70.140000000000001 110.864 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.592 ' N ' ' CG ' ' A' ' 174' ' ' ASP . 83.2 p -55.24 -12.38 0.97 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 71.439999999999998 110.87 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -92.59 7.12 44.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 72.349999999999994 110.859 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 72.83 -6.81 10.99 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 74.319999999999993 112.483 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.507 ' C ' HD21 ' A' ' 151' ' ' LEU . 7.7 mtpp -84.54 144.21 28.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.756 0.312 . . . . 74.120000000000005 110.922 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.554 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 20.3 ptt180 -122.98 132.77 54.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.421 . . . . 71.409999999999997 110.86 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.508 ' CA ' ' HB2' ' A' ' 151' ' ' LEU . . . 175.51 179.23 45.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.748 . . . . 74.439999999999998 112.476 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.754 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.8 ptp -126.74 149.83 49.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.763 0.316 . . . . 72.230000000000004 110.899 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.702 ' O ' ' O ' ' A' ' 168' ' ' GLN . 9.0 pt -159.21 151.65 17.7 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.625 0.726 . . . . 74.430000000000007 111.137 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.619 ' C ' ' HD3' ' A' ' 185' ' ' PRO . 53.9 Cg_endo -69.76 17.55 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.67 2.246 . . . . 62.140000000000001 112.347 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.726 HG22 ' CE2' ' A' ' 170' ' ' TRP . 0.2 OUTLIER 18.56 55.06 0.15 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.649 0.738 . . . . 63.350000000000001 111.131 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.619 ' HD3' ' C ' ' A' ' 183' ' ' PRO . 53.8 Cg_endo -69.72 19.27 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.694 2.263 . . . . 75.519999999999996 112.346 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 28.1 m-85 -120.75 23.76 10.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 73.340000000000003 110.929 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 184' ' ' VAL . 33.6 m -121.63 -172.18 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.501 . . . . 74.200000000000003 111.167 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.674 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 63.3 mm-40 -96.09 123.29 39.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 74.040000000000006 110.85 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.567 ' HA ' ' CG1' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -41.84 149.65 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 74.510000000000005 110.894 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.612 ' CD1' ' HA ' ' A' ' 166' ' ' GLU . 3.3 t80 -129.28 125.76 37.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 62.520000000000003 110.926 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.21 132.2 21.85 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.626 0.727 . . . . 61.229999999999997 110.889 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 193' ' ' ALA . 53.0 Cg_endo -69.82 85.64 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.654 2.236 . . . . 74.310000000000002 112.305 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 192' ' ' PRO . . . -33.65 -65.27 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 73.099999999999994 111.102 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 97.1 p -64.04 167.0 6.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 63.109999999999999 110.879 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -131.94 173.35 11.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 43.43 111.129 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 1.2 t -119.59 152.25 37.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.261 -0.427 . . . . 74.329999999999998 110.807 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 28.3 m -109.91 157.21 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.508 . . . . 74.109999999999999 111.17 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 74.430000000000007 110.862 -179.836 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.507 -0.237 . . . . 55.030000000000001 112.507 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -80.46 82.7 6.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.765 0.317 . . . . 65.400000000000006 111.118 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 4.4 mmt -52.98 -18.95 2.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 74.310000000000002 110.885 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.6 133.07 11.6 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 72.040000000000006 112.494 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 53.3 p -105.81 -8.97 17.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.894 0.378 . . . . 51.420000000000002 110.845 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.32 56.15 0.79 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.754 -0.736 . . . . 54.329999999999998 112.474 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 89.1 t -112.19 133.48 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.831 0.348 . . . . 65.349999999999994 111.125 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.0 mm -81.34 133.86 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 72.510000000000005 111.107 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.2 mt -90.98 113.48 25.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 74.209999999999994 110.933 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -109.62 149.66 29.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 73.530000000000001 110.837 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -124.56 34.62 4.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 75.409999999999997 110.892 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -95.23 138.71 32.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 63.509999999999998 110.881 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -113.49 -75.49 0.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 75.049999999999997 110.897 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.618 ' HB1' ' HE1' ' A' ' 169' ' ' TRP . . . -174.78 135.92 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 61.299999999999997 111.07 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.434 ' HG3' ' HB2' ' A' ' 183' ' ' PRO . 4.3 mm-40 -95.61 118.86 33.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 73.319999999999993 110.863 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.864 ' HA ' ' HA ' ' A' ' 167' ' ' GLU . 0.9 OUTLIER -104.73 112.84 26.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 61.240000000000002 110.942 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.912 HG13 ' HA ' ' A' ' 189' ' ' LYS . 3.6 t -158.86 173.97 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 71.329999999999998 111.099 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.733 ' H ' HG12 ' A' ' 137' ' ' VAL . 6.5 ttt180 -113.71 148.03 37.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 74.140000000000001 110.863 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.773 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . . . -62.09 131.55 49.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 64.200000000000003 111.073 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -134.12 -69.12 0.54 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 74.409999999999997 110.922 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -81.38 -176.95 6.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 73.310000000000002 110.888 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.5 ' O ' ' CG ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER -138.48 110.57 7.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 71.150000000000006 110.85 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.642 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 1.8 t80 -123.74 145.89 48.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 75.129999999999995 110.874 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -102.8 144.42 31.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 73.129999999999995 110.9 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -129.62 166.96 21.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.707 -0.759 . . . . 72.519999999999996 112.496 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -124.54 23.13 8.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.807 0.337 . . . . 73.239999999999995 110.854 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.438 ' CB ' ' OD1' ' A' ' 150' ' ' ASP . 1.1 m-20 -98.38 132.71 43.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 64.120000000000005 110.869 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -77.44 -29.87 53.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 75.209999999999994 110.836 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -88.86 18.72 4.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 53.049999999999997 110.884 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.513 ' HB3' ' CG2' ' A' ' 182' ' ' ILE . 0.2 OUTLIER -149.39 178.12 9.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 74.230000000000004 110.847 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.855 HD21 ' O ' ' A' ' 178' ' ' LYS . 1.1 tm? -145.4 134.12 10.99 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.592 0.711 . . . . 72.239999999999995 110.983 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.806 ' HD2' HD22 ' A' ' 151' ' ' LEU . 53.7 Cg_endo -69.73 137.96 36.77 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.248 . . . . 63.229999999999997 112.329 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.91 ' HB3' HG13 ' A' ' 184' ' ' VAL . 24.6 p90 -89.28 143.99 26.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 73.400000000000006 110.882 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 142' ' ' ASP . 13.3 mmtt -109.84 162.03 14.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 70.239999999999995 110.911 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' A' ' 157' ' ' ASP . 10.7 ttpp -91.94 94.94 9.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 74.25 110.93 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 155' ' ' LYS . . . 30.6 32.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 43.119999999999997 112.514 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 155' ' ' LYS . 10.8 t0 -82.71 179.2 7.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.793 0.33 . . . . 75.439999999999998 110.863 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 23.3 mm -95.16 103.51 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 62.43 111.119 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.575 HD13 ' OD1' ' A' ' 174' ' ' ASP . 0.9 OUTLIER -152.54 163.39 39.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 54.149999999999999 110.902 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.698 ' O ' ' O ' ' A' ' 173' ' ' GLU . 4.5 tpp85 -92.49 80.72 4.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 74.439999999999998 110.879 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.953 ' HA ' ' HB3' ' A' ' 172' ' ' ALA . 0.2 OUTLIER -148.16 119.82 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.17 -0.468 . . . . 74.010000000000005 111.166 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.635 ' H ' ' CB ' ' A' ' 172' ' ' ALA . 24.6 mtt180 -69.0 70.85 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.310000000000002 110.864 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.465 ' HA ' ' CG ' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -79.56 127.13 31.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 61.350000000000001 110.893 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.767 ' O ' ' O ' ' A' ' 167' ' ' GLU . 0.3 OUTLIER -83.56 119.04 73.15 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.563 0.697 . . . . 75.030000000000001 110.888 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.596 ' O ' ' CA ' ' A' ' 138' ' ' ARG . 53.6 Cg_endo -69.83 -53.52 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.658 2.239 . . . . 75.340000000000003 112.353 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.62 ' HA ' ' CD1' ' A' ' 190' ' ' TYR . 36.5 tt0 -75.16 -3.04 30.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 65.319999999999993 110.871 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.864 ' HA ' ' HA ' ' A' ' 136' ' ' TYR . 3.2 mt-10 -141.73 142.7 33.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.310000000000002 110.897 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.769 ' N ' ' H ' ' A' ' 137' ' ' VAL . 0.8 OUTLIER -83.96 24.58 0.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 63.200000000000003 110.914 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.626 ' C ' ' HD1' ' A' ' 170' ' ' TRP . 96.3 m95 -110.8 110.59 21.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 74.150000000000006 110.958 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.976 ' CE2' HG21 ' A' ' 184' ' ' VAL . 5.7 m0 -117.92 160.15 21.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.432 . . . . 74.439999999999998 110.952 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 172' ' ' ALA . 1.3 t30 -160.87 104.98 1.36 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 63.299999999999997 110.937 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.953 ' HB3' ' HA ' ' A' ' 161' ' ' ILE . . . 173.13 177.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 64.099999999999994 111.147 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.698 ' O ' ' O ' ' A' ' 160' ' ' ARG . 16.4 tt0 -86.04 107.34 17.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 73.430000000000007 110.891 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.619 ' HB3' HD11 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -72.67 174.22 7.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 70.140000000000001 110.864 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.592 ' N ' ' CG ' ' A' ' 174' ' ' ASP . 83.2 p -55.24 -12.38 0.97 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 55.119999999999997 110.87 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.402 ' CB ' ' HD3' ' A' ' 178' ' ' LYS . 5.7 mm-40 -92.59 7.12 44.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 72.349999999999994 110.859 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 72.83 -6.81 10.99 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 74.319999999999993 112.483 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.855 ' O ' HD21 ' A' ' 151' ' ' LEU . 7.7 mtpp -84.54 144.21 28.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.756 0.312 . . . . 74.120000000000005 110.922 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 20.3 ptt180 -122.98 132.77 54.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.421 . . . . 71.409999999999997 110.86 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.521 ' CA ' ' HB2' ' A' ' 151' ' ' LEU . . . 175.51 179.23 45.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.748 . . . . 63.109999999999999 112.476 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.755 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.8 ptp -126.74 149.83 49.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.763 0.316 . . . . 72.230000000000004 110.899 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.702 ' O ' ' O ' ' A' ' 168' ' ' GLN . 9.0 pt -159.21 151.65 17.7 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.625 0.726 . . . . 64.129999999999995 111.137 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.624 ' C ' ' HD3' ' A' ' 185' ' ' PRO . 53.9 Cg_endo -69.76 17.55 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.67 2.246 . . . . 61.140000000000001 112.347 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.976 HG21 ' CE2' ' A' ' 170' ' ' TRP . 0.2 OUTLIER 18.56 55.06 0.15 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.649 0.738 . . . . 63.350000000000001 111.131 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.624 ' HD3' ' C ' ' A' ' 183' ' ' PRO . 53.8 Cg_endo -69.72 19.27 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.694 2.263 . . . . 75.519999999999996 112.346 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.635 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 28.1 m-85 -120.75 23.76 10.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 65.140000000000001 110.929 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.802 HG23 HG11 ' A' ' 137' ' ' VAL . 33.6 m -121.63 -172.18 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.501 . . . . 70.25 111.167 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.674 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 63.3 mm-40 -96.09 123.29 39.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 74.040000000000006 110.85 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.912 ' HA ' HG13 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -41.84 149.65 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 74.510000000000005 110.894 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.62 ' CD1' ' HA ' ' A' ' 166' ' ' GLU . 3.3 t80 -129.28 125.76 37.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 62.520000000000003 110.926 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.47 ' H ' ' CD ' ' A' ' 191' ' ' ARG . 0.0 OUTLIER -111.21 132.2 21.85 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.626 0.727 . . . . 45.210000000000001 110.889 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 193' ' ' ALA . 53.0 Cg_endo -69.82 85.64 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.654 2.236 . . . . 44.450000000000003 112.305 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 192' ' ' PRO . . . -33.65 -65.27 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 73.099999999999994 111.102 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 97.1 p -64.04 167.0 6.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 43.509999999999998 110.879 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -131.94 173.35 11.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 41.520000000000003 111.129 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 1.2 t -119.59 152.25 37.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.261 -0.427 . . . . 74.329999999999998 110.807 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 28.3 m -109.91 157.21 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.508 . . . . 65.530000000000001 111.17 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 74.430000000000007 110.862 -179.836 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.507 -0.237 . . . . 55.03 112.507 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -80.46 82.7 6.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.765 0.317 . . . . 65.4 111.118 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 4.4 mmt -52.98 -18.95 2.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 74.31 110.885 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.6 133.07 11.6 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 72.04 112.494 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 53.3 p -105.81 -8.97 17.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.894 0.378 . . . . 51.42 110.845 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.32 56.15 0.79 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.754 -0.736 . . . . 54.33 112.474 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 89.1 t -112.19 133.48 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.831 0.348 . . . . 65.35 111.125 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.0 mm -81.34 133.86 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 72.51 111.107 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.2 mt -90.98 113.48 25.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 74.21 110.933 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -109.62 149.66 29.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 73.53 110.837 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -124.56 34.62 4.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 75.41 110.892 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -95.23 138.71 32.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 63.51 110.881 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -113.49 -75.49 0.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 75.05 110.897 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.618 ' HB1' ' HE1' ' A' ' 169' ' ' TRP . . . -174.78 135.92 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 61.3 111.07 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.434 ' HG3' ' HB2' ' A' ' 183' ' ' PRO . 4.3 mm-40 -95.61 118.86 33.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 73.32 110.863 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.864 ' HA ' ' HA ' ' A' ' 167' ' ' GLU . 0.9 OUTLIER -104.73 112.84 26.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 61.24 110.942 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.912 HG13 ' HA ' ' A' ' 189' ' ' LYS . 3.6 t -158.86 173.97 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 71.33 111.099 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.733 ' H ' HG12 ' A' ' 137' ' ' VAL . 6.5 ttt180 -113.71 148.03 37.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 74.14 110.863 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.773 ' HB2' ' CZ2' ' A' ' 170' ' ' TRP . . . -62.09 131.55 49.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 64.2 111.073 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -134.12 -69.12 0.54 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 74.41 110.922 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -81.38 -176.95 6.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 73.31 110.888 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.5 ' CG ' ' O ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER -138.48 110.57 7.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 71.15 110.85 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.642 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 1.8 t80 -123.74 145.89 48.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 75.13 110.874 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -102.8 144.42 31.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 73.13 110.9 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -129.62 166.96 21.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.707 -0.759 . . . . 72.52 112.496 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -124.54 23.13 8.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.807 0.337 . . . . 73.24 110.854 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.438 ' CB ' ' OD1' ' A' ' 150' ' ' ASP . 1.1 m-20 -98.38 132.71 43.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 64.12 110.869 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -77.44 -29.87 53.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 75.21 110.836 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -88.86 18.72 4.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 53.05 110.884 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.513 ' HB3' ' CG2' ' A' ' 182' ' ' ILE . 0.2 OUTLIER -149.39 178.12 9.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 74.23 110.847 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.855 HD21 ' O ' ' A' ' 178' ' ' LYS . 1.1 tm? -145.4 134.12 10.99 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.592 0.711 . . . . 72.24 110.983 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.806 ' HD2' HD22 ' A' ' 151' ' ' LEU . 53.7 Cg_endo -69.73 137.96 36.77 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.248 . . . . 63.23 112.329 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.91 ' HB3' HG13 ' A' ' 184' ' ' VAL . 24.6 p90 -89.28 143.99 26.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 73.4 110.882 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 142' ' ' ASP . 13.3 mmtt -109.84 162.03 14.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 70.24 110.911 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' A' ' 157' ' ' ASP . 10.7 ttpp -91.94 94.94 9.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 74.25 110.93 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 155' ' ' LYS . . . 30.6 32.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 43.12 112.514 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 155' ' ' LYS . 10.8 t0 -82.71 179.2 7.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.793 0.33 . . . . 75.44 110.863 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 23.3 mm -95.16 103.51 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 62.43 111.119 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.575 HD13 ' OD1' ' A' ' 174' ' ' ASP . 0.9 OUTLIER -152.54 163.39 39.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 54.15 110.902 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.698 ' O ' ' O ' ' A' ' 173' ' ' GLU . 4.5 tpp85 -92.49 80.72 4.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 74.44 110.879 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.953 ' HA ' ' HB3' ' A' ' 172' ' ' ALA . 0.2 OUTLIER -148.16 119.82 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.17 -0.468 . . . . 74.01 111.166 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.635 ' H ' ' CB ' ' A' ' 172' ' ' ALA . 24.6 mtt180 -69.0 70.85 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.31 110.864 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.465 ' HA ' ' CG ' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -79.56 127.13 31.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 61.35 110.893 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.767 ' O ' ' O ' ' A' ' 167' ' ' GLU . 0.3 OUTLIER -83.56 119.04 73.15 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.563 0.697 . . . . 75.03 110.888 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.596 ' O ' ' CA ' ' A' ' 138' ' ' ARG . 53.6 Cg_endo -69.83 -53.52 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.658 2.239 . . . . 75.34 112.353 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.62 ' HA ' ' CD1' ' A' ' 190' ' ' TYR . 36.5 tt0 -75.16 -3.04 30.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 65.32 110.871 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.864 ' HA ' ' HA ' ' A' ' 136' ' ' TYR . 3.2 mt-10 -141.73 142.7 33.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.31 110.897 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.769 ' N ' ' H ' ' A' ' 137' ' ' VAL . 0.8 OUTLIER -83.96 24.58 0.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 63.2 110.914 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.626 ' C ' ' HD1' ' A' ' 170' ' ' TRP . 96.3 m95 -110.8 110.59 21.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 74.15 110.958 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.976 ' CE2' HG21 ' A' ' 184' ' ' VAL . 5.7 m0 -117.92 160.15 21.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.432 . . . . 74.44 110.952 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 172' ' ' ALA . 1.3 t30 -160.87 104.98 1.36 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 63.3 110.937 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.953 ' HB3' ' HA ' ' A' ' 161' ' ' ILE . . . 173.13 177.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 64.1 111.147 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.698 ' O ' ' O ' ' A' ' 160' ' ' ARG . 16.4 tt0 -86.04 107.34 17.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 73.43 110.891 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.619 ' HB3' HD11 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -72.67 174.22 7.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 70.14 110.864 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.592 ' N ' ' CG ' ' A' ' 174' ' ' ASP . 83.2 p -55.24 -12.38 0.97 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 55.12 110.87 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.402 ' CB ' ' HD3' ' A' ' 178' ' ' LYS . 5.7 mm-40 -92.59 7.12 44.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 72.35 110.859 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 72.83 -6.81 10.99 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 74.32 112.483 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.855 ' O ' HD21 ' A' ' 151' ' ' LEU . 7.7 mtpp -84.54 144.21 28.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.756 0.312 . . . . 74.12 110.922 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 20.3 ptt180 -122.98 132.77 54.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.421 . . . . 71.41 110.86 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.521 ' CA ' ' HB2' ' A' ' 151' ' ' LEU . . . 175.51 179.23 45.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.748 . . . . 63.11 112.476 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.755 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.8 ptp -126.74 149.83 49.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.763 0.316 . . . . 72.23 110.899 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.702 ' O ' ' O ' ' A' ' 168' ' ' GLN . 9.0 pt -159.21 151.65 17.7 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.625 0.726 . . . . 64.13 111.137 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.624 ' C ' ' HD3' ' A' ' 185' ' ' PRO . 53.9 Cg_endo -69.76 17.55 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.67 2.246 . . . . 61.14 112.347 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.976 HG21 ' CE2' ' A' ' 170' ' ' TRP . 0.2 OUTLIER 18.56 55.06 0.15 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.649 0.738 . . . . 63.35 111.131 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.624 ' HD3' ' C ' ' A' ' 183' ' ' PRO . 53.8 Cg_endo -69.72 19.27 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.694 2.263 . . . . 75.52 112.346 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.635 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 28.1 m-85 -120.75 23.76 10.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 65.14 110.929 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.802 HG23 HG11 ' A' ' 137' ' ' VAL . 33.6 m -121.63 -172.18 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.501 . . . . 70.25 111.167 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.674 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 63.3 mm-40 -96.09 123.29 39.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 74.04 110.85 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.912 ' HA ' HG13 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -41.84 149.65 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 74.51 110.894 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.62 ' CD1' ' HA ' ' A' ' 166' ' ' GLU . 3.3 t80 -129.28 125.76 37.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 62.52 110.926 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.47 ' CD ' ' H ' ' A' ' 191' ' ' ARG . 0.0 OUTLIER -111.21 132.2 21.85 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.626 0.727 . . . . 45.21 110.889 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 193' ' ' ALA . 53.0 Cg_endo -69.82 85.64 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.654 2.236 . . . . 44.45 112.305 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 192' ' ' PRO . . . -33.65 -65.27 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 73.1 111.102 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 97.1 p -64.04 167.0 6.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 43.51 110.879 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -131.94 173.35 11.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 41.52 111.129 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 1.2 t -119.59 152.25 37.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.261 -0.427 . . . . 74.33 110.807 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 28.3 m -109.91 157.21 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.508 . . . . 65.53 111.17 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 74.43 110.862 -179.836 . . . . . . . . 0 0 . 1 stop_ save_